British pharmaceutical company Synairgen has claimed that its new respiratory coronavirus treatment has reduced the number of hospitalized patients with Covid-19 needing intensive care in a clinical trial. The company said that their nebulizer treatment produced a 79% lower risk of patients developing serious illness than those who received a …
Read More »Synairgen says small trial of coronavirus treatment could indicate “big breakthrough”
